Cyclopentasiloxane

1. Ingredient Overview

1. Common name and identity: Cyclopentasiloxane (decamethylcyclopentasiloxane; D5)
2. Ingredient category: Volatile cyclic siloxane
3. Natural or commercial origin: Industrially manufactured cyclic siloxane

Plain-language summary: D5 is a clear, low-viscosity silicone fluid that spreads quickly and evaporates, leaving deposited oils, polymers, resins, powders, or pigments behind. It is different from nonvolatile dimethicone. Purity, residual D4 and D6, evaporation profile, flash point, and intended market and product category are core qualification attributes. [S1–S3]

Why Cyclopentasiloxane Matters
Ingredient identity, source, grade, concentration basis, documentation, and finished-product behavior must be qualified together. A familiar INCI name alone does not establish equivalence or quality.

2. Functional Benefits

1. Primary functions: Support the ingredient's established cosmetic role in a safe, stable, and appropriately positioned finished product
2. Secondary functions: Improve sensory, structure, delivery, conditioning, protection, or processing where the exact grade and formula support the outcome
3. Cosmetic functions: Skin conditioning, hair conditioning, solvent, volatile carrier, sensory modifier
4. Mechanism-based benefits: Cyclopentasiloxane lowers surface tension, improves spread, reduces greasy after-feel, and transports nonvolatile silicone gums, resins, colorants, and compatible actives. It evaporates after application and contributes little persistent occlusive film by itself. Performance depends on volatility, blend composition, use level, film formers, and package closure.

3. Mechanism of Action and Chemistry

Chemical Classification

D5 is a cyclic molecule containing five repeating dimethylsiloxane units. Unlike polymeric dimethicone, it has a defined molecular structure and appreciable volatility. Environmental regulation focuses on persistence and bioaccumulation rather than simply on immediate cosmetic sensory performance.

Skin, Hair, or Formula Interaction

Performance depends on the exact grade, concentration, vehicle, co-ingredients, application area, use pattern, package, and target consumer. Ingredient-level rationale should not be presented as proof of a finished-product outcome.

Stability Considerations

Stability Profile
Control heat, light, oxygen, moisture, metals, contamination, physical state, compatible processing, storage, and packaging as relevant to the exact ingredient and complete formula.

4. Source and Raw Material Origin

1. Raw material source: Supplier approval should establish legal manufacturer and site, assay, D4/D6 and other cyclic distribution, water, acidity, nonvolatile residue, metals or catalyst residues where relevant, package and transport requirements, and regulatory statements for every target market. Blends sold in silicone elastomers or gums require complete carrier composition.
2. Geographic origin: Document feedstock or raw-material origin, intermediate processors, manufacturing and refining sites, finishing or blending sites, distributor chain, and final packaging location.
3. Manufacturing pathway: Feedstock preparation → conversion, extraction, polymerization, refining, or fractionation → purification and finishing → testing → controlled packaging.
4. Renewability: Evaluate feedstocks, land or mineral use where relevant, water, energy, solvents or reagents, emissions, waste, transport, certification scope, and chain of custody. Origin alone does not prove sustainability.

Sourcing Transparency
Approve the exact identity, legal manufacturer, production sites, complete composition, source chain, processing method, and change-notification terms—not only a distributor's product name.

5. Manufacturing and Processing

1. Production method: D5 is produced through controlled siloxane chemistry, equilibration or cyclization, then distillation and purification. Release testing should include identity, assay, cyclic-siloxane profile, refractive index, density, viscosity, volatility or nonvolatile residue, water, color, odor, acidity, and flash point. Bulk handling requires evaporation-loss and closure controls.
2. Standardization: Confirm identity, composition or assay basis, physical properties, impurities, contaminants, microbiology where relevant, and stability requirements.
3. Quality control: Identity / purity / composition / physical properties / contaminants / residual materials / microbiology where relevant / sensory quality / stability
4. Consistency considerations: Feedstock, route, process controls, purification, finishing, physical form, packaging, transport, and storage can change lot performance.

Quality Control Steps

• Confirm identity with methods capable of distinguishing the claimed grade, composition, source, or material family.
• Reconcile the specification, certificate of analysis, test methods, lot, legal manufacturer, site, and expiry or retest date.
• Review impurities, contaminants, adulterants, residual processing materials, and microbiology using a source- and process-specific risk assessment.
• Verify physical and sensory properties on the same basis used for formulation, manufacturing, and claims.
• Require stability, storage, transport, opened-container, change-notification, complaint, recall, and continuity information.

6. Safety, Toxicology, and Regulatory Status

Cosmetic Regulatory Status

CIR reviewed cyclomethicone ingredients including Cyclopentasiloxane and concluded they are safe in cosmetics in the practices of use described. Product safety still requires exposure-specific review, especially for sprays, powders, and possible inhalation. Separately, EU REACH restrictions address environmental properties: D4 and D5 are restricted in wash-off cosmetics at 0.1% or more, and Regulation (EU) 2024/1328 extends restrictions to D4, D5, and D6 in leave-on cosmetics after the specified transition, generally from 6 June 2027. [S2–S4]

In the United States, cosmetics must be safe under labeled or customary conditions of use and properly labeled. Drug claims or use as an OTC active require the applicable drug pathway. In the European Union, assess the complete formula under current cosmetics and, where relevant, REACH requirements.

Before launch, confirm ingredient status, concentration, exposure, claims, warnings, labeling, safety assessment, and regulatory requirements for each target market.

Safety Profile

• Evaluate safety for the exact grade, concentration, exposure area, use pattern, population, and complete formula.
• Review impurities, contaminants, allergens, inhalation or mucosal exposure, interactions, and vulnerable users where relevant.
• Avoid disease-treatment claims, absolute promises, and conclusions that exceed the supporting evidence.
• Maintain lot traceability, complaint handling, adverse-event procedures, and current market-specific regulatory documentation.

Regulatory Compliance Considerations
Ingredient permission, concentration, exposure, claims, labeling, purity, and manufacturing controls must be reviewed together for each target market.

7. Clinical Studies and Scientific Evidence

Evidence Summary

The strongest support is for established volatile-carrier and sensory functions. Claims that D5 improves active penetration, is breathable, detoxifies, or is automatically safer than other emollients require evidence. Environmental hazard and cosmetic user safety are different assessment questions and should not be conflated.

Study Types and Endpoints

• Analytical and laboratory studies: Identity, composition, stability, compatibility, physical behavior, and plausible cosmetic function
• Human cosmetic studies: Hydration, softness, smoothness, barrier-related measures, sensory, tolerability, hair performance, or color-cosmetic endpoints as relevant
• Finished-product studies: Exact grade, concentration, vehicle, application area, directions, target population, package, and shelf-life performance

Limitations

Published studies may use different grades, concentrations, vehicles, combinations, populations, endpoints, or supplier-funded materials. Results should not be transferred without confirming identity, composition, exposure, formula, and evidence relevance.

Clinical Evidence at a Glance
Claims should match the exact ingredient grade, concentration, finished formula, target population, study duration, application pattern, and measured endpoint.

8. Formulation and Application Guidance

Process in closed or covered equipment where practical and minimize long hot holds. Account for evaporation during batching, filling, stability, and consumer use. Verify viscosity and solids after loss, elastomer or resin compatibility, pigment wetting, package vapor transmission, closure torque, flammability classification, and market-specific legal concentration.

Typical Use Levels

Set the level from the exact grade, intended function, finished-product safety assessment, sensory target, processing behavior, evidence, and applicable market rules.

Compatibility

Compatibility is formula-specific. Evaluate polarity, solubility or dispersion, emulsifier and rheology systems, heat and shear, pH where relevant, preservation, oxidation, sensory, and package interactions.

Formulation Challenges and Solutions

Delivery Systems

1. Volatile silicone systems: Minimize open processing and long hot holds; control evaporation during batching, filling, and stability.
2. Elastomer and resin dispersions: Confirm the full carrier composition, solids, compatibility, deposition, and post-evaporation film.
3. Color and hair products: Test dry-down, transfer, pigment wetting, package vapor loss, closure integrity, and target-market concentration.

Formulator's Note
Use the supplier's grade-specific process limits as a starting point, then verify identity, composition, appearance, sensory profile, physical stability, microbiology where relevant, preservative efficacy, package compatibility, and claims throughout finished-product shelf life.

9. Products and Applications

Common Product Types

Primers, foundations, antiperspirants, hair serums, conditioners, styling products, sunscreens, and dry-touch skincare where target-market restrictions permit.

Target Consumers

Brands using volatile-carrier sensory or delivery systems that can support current regulatory review, regional formula strategy, and reformulation timelines.

Positioning

Lead with precise identity and current market status. EU/EEA wash-off and 2027 leave-on restrictions must be addressed directly; an old supplier compliance letter is insufficient.

Real-World Product Examples
Select the format and level by ingredient behavior, target consumer, sensory expectations, manufacturing capability, safety assessment, claims, target market, and shelf-life requirements.

10. Supply Chain, Sustainability, and Quality Considerations

Supply Chain Characteristics

1. Supply risks: Risks include residual D4/D6 above specification, regulatory statements that predate the 2024 restriction, evaporation losses, contaminated returnable containers, mislabeled cyclomethicone blends, single-source reformulation pressure, and failure to separate current legal use from post-transition requirements.
2. Continuity: Review feedstock availability, manufacturing capacity, quality holds, logistics, regulatory transitions, and qualified backup options.
3. Lead times and price: Grade, purity, testing, documentation, packaging, order volume, certification, and regulatory support affect commercial terms.

Sustainability

• Request source- and site-specific information on feedstocks, water, energy, solvents or reagents, waste, emissions, and packaging.
• Verify environmental and social certifications, issuing bodies, validity, custody model, and exact facility and product scope.
• Do not treat plant, mineral, petroleum, synthetic, or silicone origin as automatic proof of environmental benefit or harm.

Adulteration and Quality Risks

1. Risk level: Higher when identity, composition, manufacturing site, source claims, or certificate traceability are unclear
2. Common issues: Substitution, dilution, undisclosed blends or carriers, incorrect assay or composition basis, contamination, specification drift, and unsupported origin or certification claims
3. Detection methods: Orthogonal identity and composition testing, impurity and contaminant review, physical and sensory checks, document reconciliation, retained-sample comparison, and lot traceability

Supplier Evaluation Checklist

• Exact identity, source, grade, composition, and functional basis
• Legal manufacturer, production and finishing sites, countries of origin, and distributor chain
• Current specification, methods, and representative certificates of analysis
• Impurity, contaminant, adulteration, allergen, residual-material, and microbiological controls where relevant
• Stability, storage, transport, shelf-life, packaging, and opened-container requirements
• Evidence matching the exact grade, concentration, target use, and proposed claims
• Regulatory, sustainability, origin, certification, and social-impact documentation covering the exact supply chain
• Change notification, complaint handling, recall readiness, audit status, and business continuity

Quality Markers

• Confirmed identity, source, legal manufacturer, production site, grade, lot, and document traceability
• Composition or functional property tested on the same basis used in formulation and supplier approval
• Controlled impurities, contaminants, adulterants, residual processing materials, and microbiology where relevant
• Consistent physical, sensory, and processing performance
• Finished-product stability in the intended packaging and distribution pathway
• Change-notification, complaint, recall, and business-continuity controls

11. How Does Cyclopentasiloxane Compare to Related Ingredients?

Selection Considerations
Choose the grade by target consumer, intended cosmetic function, sensory needs, safety, regulatory path, analytical capability, source evidence, manufacturing requirements, and supply continuity—not by marketing familiarity alone.